CYP106A2—A versatile biocatalyst with high potential for biotechnological production of selectively hydroxylated steroid and terpenoid compounds

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1866, Issue 1, 2018, Pages 11-22

  Schmitz, Daniela ^a   Janocha, Simon ^a   Kiss, Flora Marta ^a   Bernhardt, Rita ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Biotechnology; CYP106A2; Cytochrome P450; Redox partner; Steroid; Terpenoid

Indexed keywords

CYTOCHROME P106 A2; CYTOCHROME P450; STEROID; TERPENE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; 15BETA-HYDROXYLASE CYP106A2, BACILLUS MEGATERIUM; BACTERIAL PROTEIN; DITERPENE;

BIOCATALYST; BIOTECHNOLOGICAL PRODUCTION; ENZYME ENGINEERING; ENZYME SUBSTRATE; HUMAN; PRIORITY JOURNAL; REVIEW; STEROID HYDROXYLATION; BACILLUS MEGATERIUM; BIOCATALYSIS; BIOTECHNOLOGY; CHEMISTRY; DIRECTED MOLECULAR EVOLUTION; ENZYMOLOGY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HYDROXYLATION; METABOLISM; MOLECULAR MODEL; PROCEDURES; PROTEIN ENGINEERING; PROTEIN SECONDARY STRUCTURE; STEREOISOMERISM; SYNTHESIS;

BACILLUS MEGATERIUM; BACTERIAL PROTEINS; BIOCATALYSIS; BIOTECHNOLOGY; CYTOCHROME P-450 ENZYME SYSTEM; DIRECTED MOLECULAR EVOLUTION; DITERPENES; ESCHERICHIA COLI; GENE EXPRESSION; HYDROXYLATION; MODELS, MOLECULAR; PROTEIN ENGINEERING; PROTEIN STRUCTURE, SECONDARY; STEREOISOMERISM; STEROIDS; TERPENES;

EID: 85029412394     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2017.07.011     Document Type: Review

References (66)

1. Bernhardt, R., Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 124 (2006), 128–145.
2. Bernhardt, R., Urlacher, V.B., Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations. Appl. Microbiol. Biotechnol. 98 (2014), 6185–6203.
3. Hlavica, P., Models and mechanisms of O[sbnd]O bond activation by cytochrome P450. Eur. J. Biochem. 271 (2004), 4335–4360.
4. Nelson, D., The cytochrome P450 homepage. Hum. Genomics 4 (2009), 59–65.
5. Nelson, D.R., Cytochrome P450 diversity in the tree of life. Biochim. Biophys. Acta Proteins Proteomics, 2017 (in press).
6. Kelly, S.L., Kelly, D.E., Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 368, 2013, 20120476.
7. Omura, T., Contribution of cytochrome P450 to the diversification of eukaryotic organisms. Biotechnol. Appl. Biochem. 60 (2013), 4–8.
8. Omura, T., Structural diversity of cytochrome P450 enzyme system. J. Biochem. 147 (2010), 297–306.
9. Kawashima, A., Satta, Y., Substrate-dependent evolution of cytochrome P450: rapid turnover of the detoxification-type and conservation of the biosynthesis-type. PLoS One, 9, 2014, e100059.
10. Podust, L., Sherman, D., Diversity of P450 enzymes in the biosynthesis of natural products. Nat. Prod. Rep. 29 (2012), 1251–1266.
11. Sinha, S., Shen, X., Gallazzi, F., Li, Q., Zmijewski, J.W., Lancaster, J.R., Gates, K.S., Generation of reactive oxygen species mediated by 1-hydroxyphenazine, a virulence factor of Pseudomonas aeruginosa. Chem. Res. Toxicol. 28 (2015), 175–181.
12. Urlacher, V.B., Eiben, S., Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol. 24 (2006), 324–330.
13. Hannemann, F., Bichet, A., Ewen, K.M., Bernhardt, R., Cytochrome P450 systems—biological variations of electron transport chains. Biochim. Biophys. Acta 1770 (2007), 330–344.
14. Berg, A., Gustafsson, J., Ingelman-Sundberg, M., Characterization of a cytochrome P-450-dependent steroid hydroxylase system present in Bacillus megaterium. J. Biol. Chem. 251 (1976), 2831–2838.
15. Brill, E., Hannemann, F., Zapp, J., Bruning, G., Jauch, J., Bernhardt, R., A new cytochrome P450 system from Bacillus megaterium DSM319 for the hydroxylation of 11-keto-beta-boswellic acid (KBA). Appl. Microbiol. Biotechnol. 98 (2014), 1701–1717.
16. Gotoh, O., Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem. 267 (1992), 83–90.
17. Rauschenbach, R., Isernhagen, M., Noeske-Jungblut, C., Boidol, W., Siewert, G., Cloning sequencing and expression of the gene for cytochrome P450meg, the steroid-15β-monooxygenase from Bacillus megaterium ATCC 13368. Mol. Gen. Genet. 241 (1993), 170–176.
18. Bleif, S., Hannemann, F., Zapp, J., Hartmann, D., Jauch, J., Bernhardt, R., A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-beta-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl. Microbiol. Biotechnol. 93 (2012), 1135–1146.
19. Janocha, S., Schmitz, D., Bernhardt, R., Terpene hydroxylation with microbial cytochrome P450 monooxygenases. Adv. Biochem. Eng. Biotechnol., 148, 2015 (215-150).
20. Janocha, S., Carius, Y., Hutter, M., Lancaster, C.R.D., Bernhardt, R., Crystal structure of CYP106A2 in substrate-free and substrate-bound form. Chembiochem 17 (2016), 852–860.
21. Bleif, S., Hannemann, F., Lisurek, M., Kries, J., Zapp, J., Dietzen, M., Antes, I., Bernhardt, R., Identification of CYP106A2 as a regioselective allylic bacterial diterpene hydroxylase. Chembiochem 12 (2011), 576–582.
22. Labinger, J.A., Selective alkane oxidation: hot and cold approaches to a hot problem. J. Mol. Catal. 220 (2004), 27–35.
23. Schulz, S., Girhard, M., Urlacher, V.B., Biocatalysis: key to selective oxidations. ChemCatChem 4 (2012), 1889–1895.
24. Lundemo, M.T., Woodley, J.M., Guidelines for development and implementation of biocatalytic P450 processes. Appl. Microbiol. Biotechnol. 99 (2015), 2465–2483.
25. Urlacher, V.B., Girhard, M., Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol. 30 (2012), 26–36.
26. Urlacher, V.B., Lutz-Wahl, S., Schmid, R.D., Microbial P450 enzymes in biotechnology. Appl. Microbiol. Biotechnol. 64 (2004), 317–325.
27. Schmitz, D., Zapp, J., Bernhardt, R., Hydroxylation of the triterpenoid dipterocarpol with CYP106A2 from Bacillus megaterium. FEBS J. 279 (2012), 1663–1674.
28. Virus, C., Lisurek, M., Simgen, B., Hannemann, F., Bernhardt, R., Function and engineering of the 15beta-hydroxylase CYP106A2. Biochem. Soc. Trans. 34 (2006), 1215–1218.
29. Donova, M., Egorova, O., Microbial steroid transformations: current state and prospects. Appl. Microbiol. Biotechnol. 94 (2012), 1423–1447.
30. Tong, W.Y., Dong, X., Microbial biotransformation: recent developments on steroid drugs. Recent Pat. Biotechnol. 3 (2009), 141–153.
31. McAleer, W.J., Jacob, T.A., Turnbull, L.B., Schoenewaldt, E.F., Stoudt, T.H., Hydroxylation of progesterone by Bacillus cereus and Bacillus megaterium. Arch. Biochem. Biophys. 73 (1958), 127–130.
32. Berg, A., Carlström, K., Gustafsson, J.-Å., Ingelman-Sundberg, M., Demonstration of a cytochrome P-450-dependent steroid 15β-hydroxylase in Bacillus megaterium. Biochem. Biophys. Res. Commun. 66 (1975), 1414–1423.
33. Berg, A., Ingelman-Sundberg, M., Gustafsson, J., Isolation and characterization of cytochrome P-450meg. Acta Biol. Med. Ger. 38 (1979), 333–344.
34. Berg, A., Ingelman-Sundberg, M., Gustafsson, J.A., Purification and characterization of cytochrome P-450meg. J. Biol. Chem. 254 (1979), 5264–5271.
35. Berg, A., Rafter, J.J., Studies on the substrate specificity and inducibility of cytochrome P-450meg. Biochem. J. 196 (1981), 781–786.
36. Lisurek, M., Kang, M., Hartmann, R., Bernhardt, R., Identification of monohydroxy progesterones produced by CYP106A2 using comparative HPLC and electrospray ionisation collision-induced dissociation mass spectrometry. Biochem. Biophys. Res. Commun. 319 (2004), 677–682.
37. Lisurek, M., Simgen, B., Antes, I., Bernhardt, R., Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation. Chembiochem 9 (2008), 1439–1449.
38. Kang, M., Lisurek, M., Bernhardt, R., Hartmann, R., Use of high-performance liquid chromatography/electrospray ionization collision-induced dissociation mass spectrometry for structural identification of monohydroxylated progesterones. Rapid Commun. Mass Spectrom. 18 (2004), 2795–2800.
39. Simgen, B., Contzen, J., Schwarzer, R., Bernhardt, R., Jung, C., Substrate binding to 15beta-hydroxylase (CYP106A2) probed by FT infrared spectroscopic studies of the iron ligand CO stretch vibration. Biochem. Biophys. Res. Commun. 269 (2000), 737–742.
40. Kiss, F.M., Schmitz, D., Zapp, J., Dier, T.F., Volmer, D., Bernhardt, R., Comparison of CYP106A1 and CYP106A2 from Bacillus megaterium — identification of a novel 11-oxidase activity. Appl. Microbiol. Biotechnol., 2015, 1–20.
41. Schenkman, J., Jansson, I., Spectral analyses of cytochromes P450. Methods Mol. Biol. 107 (1998), 25–33.
42. Schenkman, J., Sligar, S., Cinti, D., Substrate interaction with cytochrome P-450. Pharmacol. Ther. 12 (1981), 43–71.
43. Schmitz, D., Zapp, J., Bernhardt, R., Steroid conversion with CYP106A2—production of pharmaceutically interesting DHEA metabolites. Microb. Cell Factories, 13, 2014, 81.
44. Bagul, P., Khomane, K.S., Bansal, A.K., Investigating permeability related hurdles in oral delivery of 11-keto-β-boswellic acid. Int. J. Pharm. 464 (2014), 104–110.
45. Hannemann, F., Virus, C., Bernhardt, R., Design of an Escherichia coli system for whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylases. J. Biotechnol. 124 (2006), 172–181.
46. Zehentgruber, D., Hannemann, F., Bleif, S., Bernhardt, R., Lütz, S., Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2. Chembiochem 11 (2010), 713–721.
47. Bernhardt, R., The role of adrenodoxin in adrenal steroidogenesis. Curr. Opin. Endocrinol. 7 (2000), 109–115.
48. Ruijssenaars, H.J., Sperling, E.M.G.M., Wiegerinck, P.H.G., Brands, F.T.L., Wery, J., de Bont, J.A.M., Testosterone 15β-hydroxylation by solvent tolerant Pseudomonas putida S12. J. Biotechnol. 131 (2007), 205–208.
49. Ringle, M., Khatri, Y., Zapp, J., Hannemann, F., Bernhardt, R., Application of a new versatile electron transfer system for cytochrome P450-based Escherichia coli whole-cell bioconversions. Appl. Microbiol. Biotechnol. 97 (2013), 7741–7754.
50. Sperandeo, P., Dehò, G., Polissi, A., The lipopolysaccharide transport system of Gram-negative bacteria. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1791 (2009), 594–602.
51. Janocha, S., Zapp, J., Hutter, M., Kleser, M., Bohlmann, J., Bernhardt, R., Resin acid conversion with CYP105A1: an enzyme with potential for the production of pharmaceutically relevant diterpenoids. Chembiochem 14 (2013), 467–473.
52. Kiss, F.M., Lundemo, M.T., Zapp, J., Woodley, J.M., Bernhardt, R., Process development for the production of 15β-hydroxycyproterone acetate using Bacillus megaterium expressing CYP106A2 as whole-cell biocatalyst. Microb. Cell Factories 14 (2015), 1–13.
53. Tamm, J., Seckelmann, M., Volkwein, U., Ludwig, E., The effect of the antiandrogen IIα-hydroxyprogesterone on sebum production and cholesterol concentration of sebum. Br. J. Dermatol. 107 (1982), 63–70.
54. van der Willigen, A.H., Peereboom-Wynia, J.D., van Joost, T., Stolz, E., A preliminary study of the effect of 11a-hydroxyprogesterone on the hair growth in men suffering from androgenetic alopecia. Acta Derm. Venereol. 67 (1987), 82–85.
55. Hogg, J.A., Beal, P.F., Nathan, A.H., Lincoln, F.H., Schneider, W.P., Magerlein, B.J., Hanze, A.R., Jackson, R.W., The adrenal hormones and related compounds I. A “direct” synthesis of hydrocortisone acetate and cortisone acetate from 11α-hydroxyprogesterone. J. Am. Chem. Soc. 77 (1955), 4436–4438.
56. Perlman, D., Dutcher, J.D., Fried, J., Titus, E.O., 9alpha-hydroxyprogesterone, U.S. Patent No. 2,840,578. 1958.
57. Yoshioka, H., Asada, S., Fujita, S., Process for Production of 6b, 14ahydroxyandrost-4-ene-3,17-dione, European Patent 5: 99, 658. 1994.
58. Reetz, M.T., Biocatalysis in organic chemistry and biotechnology: past, present, and future. J. Am. Chem. Soc. 135 (2013), 12480–12496.
59. Appel, D., Schmid, R., Dragan, C.-A., Bureik, M., Urlacher, V., A fluorimetric assay for cortisol. Anal. Bioanal. Chem. 383 (2005), 182–186.
60. Virus, C., Bernhardt, R., Molecular evolution of a steroid hydroxylating cytochrome P450 using a versatile steroid detection system for screening. Lipids 43 (2008), 1133–1141.
61. Nguyen, K., Virus, C., Gunnewich, N., Hannemann, F., Bernhardt, R., Changing the regioselectivity of a P450 from C15 to C11 hydroxylation of progesterone. Chembiochem 13 (2012), 1161–1166.
62. Nikolaus, J., Nguyen, K.T., Virus, C., Riehm, J.L., Hutter, M., Bernhardt, R., Engineering of CYP106A2 for steroid 9α- and 6β-hydroxylation. Steroids 120 (2017), 41–48.
63. Nelson, D.R., Cytochrome P450 nomenclature, 2004. Phillips, I.R., Shephard, E.A., (eds.) Cytochrome P450 Protocols, 2006, Humana Press, 1–10.
64. Bleif, S., Von der Identifizierung neuer Substrate der 15beta-Hydroxylase (CYP106A2) zur Cytochrom P450 Ganzzellkatalyse in Bacillus megaterium. 2012, Saarländische Universitäts- und Landesbibliothek, Saarbrücken.
65. Schmitz, D., Hydroxylierung bioaktiver Naturstoffe mit CYP106A2 aus Bacillus megaterium - Screening, Biokatalyse und Produktcharakterisierung. 2013, Saarländische Universitäts- und Landesbibliothek, Saarbrücken.
66. Lisurek, M., Homologie-Modellierung und Protein-Engineering der Steroid-15beta-Hydroxylase (CYP106A2) aus Bacillus megaterium ATCC 13368. 2004, Saarländische Universitäts- und Landesbibliothek, Saarbrücken.